Serum Institute of India and Biocon Biologics, 2 Biopharma Companies, Agree to Restructure Equity Investment
Serum Institute of India and Biocon Biologics, 2 Biopharma Companies, Agree to Restructure Equity Investment
Archives: News
Read More
WHO Statement on the 15 meeting of the International Health Regulations (2005) Emergency Committee regarding the COVID-19 pandemic
The International Health Regulations (2005) (IHR) Emergency Committee convened its fifteenth meeting regarding the COVID-19 pandemic.
The WHO has encouraged all 195 countries to prioritize public health and well-being by refraining from collaborating with the tobacco industry
WHO strongly advises all of its members to make sure they are not collaborating with or receiving funding from the tobacco industry or its front organizations.
The USFDA Gives Final Approval to Zydus for their 0.75% Metronidazole Topical Cream
The US Food and Drug Administration has given final approval to Zydus Lifesciences Limited (together with its subsidiaries and affiliates, hereafter referred to as “Zydus”) to produce and distribute Metronidazole Topical Cream, 0.75% (USRLD: MetroCream, 0.75%).
ZyCoV-D is Approved by DCGI as a 2-dose COVID-19 Vaccine
Zydus Lifesciences Ltd., a global life sciences business focused on innovation, reported that the Drug Controller General of India (DCGI) had granted emergency use authorization (EUA) for its two dose COVID-19 vaccine, ZyCoV-D. After receiving this approval, the vaccination will now be given on days 0 and 28. The vaccine had previously been authorized for…
Treprostinil Injection is now Available in the United States: Dr. Reddy’s Laboratories
Today, a therapeutic equivalent generic drug called Treprostinil Injection was introduced to the U.S. market by Dr. Reddy’s Laboratories Ltd.
First-ever Standard on Universal Access to Rapid Tuberculosis Diagnostics is published by WHO
The World Health Organization (WHO) for the first time published the standard on Universal Access to Rapid Tuberculosis Diagnostics.
TAG-CO-VAC: WHO Technical Advisory Group on COVID-19 Vaccine Composition Discuss the Omicron Challenges
In an interim statement, the TAG-CO-VAC emphasized that all SARS-CoV-2 Variants of Concern (VOCs), including Omicron, remained to provide substantial levels of protection against severe disease.
In Bengaluru, Lupin Diagnostics opens a Regional Reference Laboratory
Bengaluru, April 12, 2023: As part of the development of its diagnostics network, leading global pharmaceutical company Lupin Limited (Lupin) today announced the opening of a brand-new, cutting-edge Regional Reference Laboratory in Bengaluru, Karnataka.
The Goal of the World Chagas Disease Day 2023 is to Integrate Primary Care-Level Universal Care and Surveillance
World Chagas Disease Day is celebrated on April 14; this year, the emphasis is on raising public knowledge of the condition, facilitating access to vital care, and instituting disease surveillance at the basic healthcare level.
